These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32820478)

  • 41. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
    Di Micco P; Russo V; Lodigiani C
    Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 44. Anticoagulation in COVID-19: DDI Perspective.
    Khiali S; Entezari-Maleki T
    Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
    [No Abstract]   [Full Text] [Related]  

  • 45. Erythema multiforme in the context of SARS-Coronavirus-2 infection.
    Sánchez-Velázquez A; Falkenhain D; Rivera Díaz R
    Med Clin (Barc); 2020 Aug; 155(3):141. PubMed ID: 32475615
    [No Abstract]   [Full Text] [Related]  

  • 46. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 47. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
    Kara E; Demirkan K; Unal S
    Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
    [No Abstract]   [Full Text] [Related]  

  • 51. Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020.
    Soeiro AM; Leal TCAT; Pereira MP; Lima EG; Figueiredo ACBDS; Petriz JLF; Precoma DB; Serrano CV
    Arq Bras Cardiol; 2020 Aug; 115(2):292-301. PubMed ID: 32876200
    [No Abstract]   [Full Text] [Related]  

  • 52. Minimizing bleeding events.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):271-272. PubMed ID: 32932523
    [No Abstract]   [Full Text] [Related]  

  • 53. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
    Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
    Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 55. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.
    Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):841-844. PubMed ID: 32386428
    [No Abstract]   [Full Text] [Related]  

  • 56. Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
    Boonyasai RT; Murthy VK; Yuen-Gee Liu G; Garibaldi BT; Brotman DJ; Streiff MB; Omron R
    Mayo Clin Proc; 2020 Oct; 95(10):2291-2293. PubMed ID: 33012363
    [No Abstract]   [Full Text] [Related]  

  • 57. Prone positioning in awake non-ICU patients with ARDS caused by COVID-19.
    Taboada M; Rodríguez N; Riveiro V; Baluja A; Atanassoff PG
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):581-583. PubMed ID: 32828956
    [No Abstract]   [Full Text] [Related]  

  • 58. Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation.
    Padley GJ; Desai SS; Weaver C; Price LC; Arachchillage DJ; Ridge CA
    Semin Thromb Hemost; 2020 Oct; 46(7):850-852. PubMed ID: 32886934
    [No Abstract]   [Full Text] [Related]  

  • 59. First COVID-19 maternal mortality in the UK associated with thrombotic complications.
    Ahmed I; Azhar A; Eltaweel N; Tan BK
    Br J Haematol; 2020 Jul; 190(1):e37-e38. PubMed ID: 32420614
    [No Abstract]   [Full Text] [Related]  

  • 60. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.